Medpace Holdings, Inc. (MEDP)

$149.6

-0.07 (-0.05%)
Rating:
Recommendation:
Buy
Symbol MEDP
Price $149.6
Beta 1.532
Volume Avg. 0.34M
Market Cap 4.797B
Shares () -
52 Week Range 126.945-231.0
1y Target Est -
DCF Unlevered MEDP DCF ->
DCF Levered MEDP LDCF ->
ROE 24.17% Buy
ROA 14.87% Buy
Operating Margin -
Debt / Equity 122.20% Buy
P/E 28.60 Strong Buy
P/B 8.63 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest MEDP news


DR. August Troendle
Healthcare
Diagnostics & Research
NASDAQ Global Select

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.